Cargando…
Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
BACKGROUND: The neddylation pathway is aberrantly overactivated in multiple human cancers and has been indicated as an effective target for anticancer therapy in clinical trials. We aimed to study whether the neddylation pathway is upregulated in pancreatic cancer and whether pevonedistat, a first-i...
Autores principales: | Xu, Junfeng, Li, Zheng, Zhuo, Qifeng, Ye, Zeng, Fan, Guixiong, Gao, Heli, Ji, Shunrong, Yu, Xianjun, Xu, Xiaowu, Liu, Wensheng, Xu, Wenyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826241/ https://www.ncbi.nlm.nih.gov/pubmed/35155257 http://dx.doi.org/10.3389/fonc.2022.822039 |
Ejemplares similares
-
FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells
por: Ye, Zeng, et al.
Publicado: (2020) -
Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
por: Zhang, Zheng, et al.
Publicado: (2021) -
Pin1 promotes pancreatic cancer progression and metastasis by activation of NF‐κB‐IL‐18 feedback loop
por: Sun, Qiqing, et al.
Publicado: (2020) -
Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
por: Zhang, Zheng, et al.
Publicado: (2022) -
Ferroptosis: Final destination for cancer?
por: Ye, Zeng, et al.
Publicado: (2020)